Aptose Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Aptose Biosciences

26/03/2024 21:01

* Aptose Biosciences Inc  APS.TO  reported a quarterly
adjusted
loss of $1.44​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-1.65.  The mean expectation of four analysts
for the quarter was for a loss of $1.59 per share. Wall Street
expected results to range from $-2.31 to $-1.04 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aptose Biosciences Inc's reported EPS for the quarter was
a loss
of $1.44​.
    * The company reported a quarterly loss of $11.96 million.
    * Aptose Biosciences Inc shares had fallen by 38.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG data March 26 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.59          -1.44          Beat
 Sep. 30 2023      -2.05          -1.76          Beat
 Jun. 30 2023      -2.01          -2.27          Missed
 Mar. 31 2023      -1.75          -2.25          Missed